MELTF and breast carcinoma: For some of these, EMT-related functions have not yet been found in breast cancer; for example, MFI2 has only been shown to mediate the EMT in melanoma, so further exploration of their roles in the EMT and chemoresistance in breast cancer is worthwhile.